TSX:CUS.DB.D - Post by User
Comment by
ocean112on Jun 13, 2015 11:30am
![](https://assets.stockhouse.com/kentico-cms/0342-00/images/Sprite.svg#id_Post_Views_Icon)
354 Views
Post# 23827276
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Seeking Alpha Article - Canexus
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Seeking Alpha Article - CanexusSimilar to Calgary, you've stated a $200M valuation is likely for ChlorAlkali. How do you arrive at $1/share possibility or something even close? Why is it so hard to translate all this great analysis to a price target of $1 a share or so? If you are saying Canexus should get a 6x or 7x multiple after paying down the debt with asset sales to a reasonable level, with the largest sodicum chlorate facility in the world, stable Brazil EBITDA, etc - then say so - cuz that brings the price target down to $1.00, but then a 6x or 7x multiple for a stable company with reasonable debt isn't reasonable - but yes - that is just my measly opinion and I will call it that.
Yes - I am not as sophisticated as some so I have to borrow reports from the brokerages, or seeking alpha guy - and try to work through thier analysis to see how they arrive at thier price targets. Brokerages state assumptions - plausible or otherwise. RBC is on record saying CUS can hit $1.00 a share (downside scenario) if they dump Chlor Alkali for nothing - but what the seeking alpha article argues is why would they do that if shareholder value is maximized by keeping the facility (btw - he/she just posted new analysis to defend exactly that - arguing Canexus should walk away for anything less that $260M using price target analysis). All I am saying is I appreciate when someone is willing to state a price target based on analysis - then defend it. I as an unsophisticated shareholder can then decide if what they say holds water, or not.
I will say - you and Calgary have actually helped me immensely to decide to ride this out. For that, I thank you. By doging the question of what would it take to get this to $1.00 a share, I'm actually feeling a lot better that there isn't a case to be made after asset sales. Sometimes no information is good information. At this price level, I might as well pick a horse that makes the best case (ie. SA article) and ride it out.